Paper33117397
SLE: Novel Postulates for Therapeutic Options.
Hosszu KK and 3 others. Front Immunol, 2020. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. SLE: Novel Postulates for Therapeutic Options. Papers, record 33117397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33117397
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lupus Erythematosus, Systemic | Major topic |
| Animals | |
| Cell Differentiation | |
| Complement C1q | |
| Dendritic Cells | |
| Humans | |
| Immune Tolerance | |
| Membrane Glycoproteins | |
| Monocytes | |
| Receptors, Complement | |
| Signal Transduction |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA008748 | NCI NIH HHS | United States | P30CA008748 | PubMed and NIH | NIH RePORTER |
| R01 AI060866 | NIAID NIH HHS | United States | R01AI060866 | PubMed and NIH | NIH RePORTER |
| R01 AI084178 | NIAID NIH HHS | United States | R01AI084178 | PubMed and NIH | NIH RePORTER |
References160
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21460208 | Plasmacytoid dendritic cells play a major role in apoptotic leukocyte-induced immune modulation. | J Immunol | 2011 | https://conductscience.org/library/papers/21460208 | PubMed |
| 2 | 8172575 | Collectin receptor (C1q receptor): structure and function. | Behring Inst Mitt | 1993 | https://conductscience.org/library/papers/8172575 | PubMed |
| 3 | 17462920 | C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB. | Immunity | 2007 | https://conductscience.org/library/papers/17462920 | PubMed |
| 4 | 16140380 | Chemotaxis of human monocyte-derived dendritic cells to complement component C1q is mediated by the receptors gC1qR and cC1qR. | Mol Immunol | 2006 | https://conductscience.org/library/papers/16140380 | PubMed |
| 5 | 17544810 | The regulatory roles of C1q. | Immunobiology | 2007 | https://conductscience.org/library/papers/17544810 | PubMed |
| 6 | 187173 | Circular-dichroism and electron-microscopy studies of human subcomponent C1q before and after limited proteolysis by pepsin. | Biochem J | 1976 | https://conductscience.org/library/papers/187173 | PubMed |
| 7 | 14707059 | Innate immune discrimination of apoptotic cells: repression of proinflammatory macrophage transcription is coupled directly to specific recognition. | J Immunol | 2004 | https://conductscience.org/library/papers/14707059 | PubMed |
| 8 | 9922153 | Evidence that C1q binds specifically to CH2-like immunoglobulin gamma motifs present in the autoantigen calreticulin and interferes with complement activation. | Biochemistry | 1998 | https://conductscience.org/library/papers/9922153 | PubMed |
| 9 | 28066413 | Complement Protein C1q Interacts with DC-SIGN via Its Globular Domain and Thus May Interfere with HIV-1 Transmission. | Front Immunol | 2016 | https://conductscience.org/library/papers/28066413 | PubMed |
| 10 | 2988513 | Molecular modelling of human complement subcomponent C1q and its complex with C1r2C1s2 derived from neutron-scattering curves and hydrodynamic properties. | Biochem J | 1985 | https://conductscience.org/library/papers/2988513 | PubMed |
| 11 | 2679537 | Chemistry and molecular genetics of C1q. | Behring Inst Mitt | 1989 | https://conductscience.org/library/papers/2679537 | PubMed |
| 12 | 20844193 | C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes. | J Immunol | 2010 | https://conductscience.org/library/papers/20844193 | PubMed |
| 13 | 18226498 | Infusion of UVB-treated splenic stromal cells induces suppression of beta cell antigen-specific T cell responses in NOD mice. | J Autoimmun | 2008 | https://conductscience.org/library/papers/18226498 | PubMed |
| 14 | 14971048 | Complement C1q regulates LPS-induced cytokine production in bone marrow-derived dendritic cells. | Eur J Immunol | 2004 | https://conductscience.org/library/papers/14971048 | PubMed |
| 15 | 15962005 | Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion. | Cell Death Differ | 2006 | https://conductscience.org/library/papers/15962005 | PubMed |
| 16 | 9466984 | Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. | J Clin Invest | 1998 | https://conductscience.org/library/papers/9466984 | PubMed |
| 17 | 8662673 | Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor. | J Biol Chem | 1996 | https://conductscience.org/library/papers/8662673 | PubMed |
| 18 | 17657313 | Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens. | J Clin Invest | 2007 | https://conductscience.org/library/papers/17657313 | PubMed |
| 19 | 12244199 | Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. | J Immunol | 2002 | https://conductscience.org/library/papers/12244199 | PubMed |
| 20 | 6318736 | Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes. | Biochem J | 1983 | https://conductscience.org/library/papers/6318736 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40625455 | Mechanism and target treatment of primary immunodeficiency diseases with systemic lupus erythematosus-like phenotype. | Pediatr Discov | 2024 | https://conductscience.org/library/papers/40625455 | PubMed |
| 36769151 | CD83 Regulates the Immune Responses in Inflammatory Disorders. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36769151 | PubMed |
| 36535812 | The complement system and human autoimmune diseases. | J Autoimmun | 2023 | https://conductscience.org/library/papers/36535812 | PubMed |
| 36417869 | A tick C1q protein alters infectivity of the Lyme disease agent by modulating interferon γ. | Cell Rep | 2022 | https://conductscience.org/library/papers/36417869 | PubMed |
| 35690780 | Associations of C-reactive protein isoforms with systemic lupus erythematosus phenotypes and disease activity. | Arthritis Res Ther | 2022 | https://conductscience.org/library/papers/35690780 | PubMed |
| 35572583 | Complement System and Alarmin HMGB1 Crosstalk: For Better or Worse. | Front Immunol | 2022 | https://conductscience.org/library/papers/35572583 | PubMed |
Genes52
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33117397
GET https://conductscience.org/api/papers/v1/33117397/references?page=2